Yeast Infection Market to Perceive Colossal Growth by 2023 at 5.2% CAGR

Pune, India, October, 2018 /press release/- Market Research Future Published a Half-Cooked Research Report on Yeast Infection Market Research Report.

The global yeast infection market is well-established and is growing pervasively. Increasing prevalence of the infection fuelled by the predominant risk factors such as widespread use of antibiotics and possibly even global warming contribute to the growth of the market. Moreover, factors such as well spread awareness towards this kind of infection and the availability of novel medications and treatment procedures are proving impetus to the market growth.

Acknowledging the kind of traction, the market perceives currently, Market Research Future (MRFR) in its recently published study report anticipates that the global yeast infection market will garner exponential accruals by 2023, registering approximately 5.2 % CAGR during the forecast period (2017-2023).

The genital area in women is prone to yeast infections. Yeast infections are a result of fungus growth that reaches a finale of inflammation, blisters or painful discharge. Certain health conditions resulting in recurrent infections in women are pregnancy, disability, premenopausal, or postmenopausal, immunocompromised patients with diabetes, or women who are taking estrogens replacements are at an increased risk for recurrent vaginal yeast infections.

Improving economic conditions worldwide that enables access to the quality and improved healthcare fuel the market growth. Additional factors propelling the market growth include the changing or unhealthy lifestyle & pollution owing to the growing urbanization & industrialization. Technological advancements in the medical science backed by the substantial investments made in the R&D activities foster the market growth of yeast infection treatments excellently, bringing about innovative treatments and medicines.

On the other hand, incidents of unmet clinical needs, drug resistance, complications occurring during treatments and side effects of the treatment are some of the factors expected to impede the market growth during the forecast period. However, factors such as rising demand for antifungal drugs and government support for research & development are expected to support the market growth.

Access Report @ https://www.marketresearchfuture.com/reports/yeast-infection-market-4228

Global Yeast Infection Market - Segments

Global yeast infection market is segmented into five Key dynamics for an easy grasp and enhanced understanding.

By Pathogens : Candida Albicans, Candida Glabrata, and Candida Rugosa, among others.
By Types : Skin Yeast Infection, Vaginal Yeast Infection, and Throat Yeast Infection, among others.
By Treatments : Drug Treatments (cream, ointment, tablet, and suppository.), and Surgery among others.
By End-Users : Hospital, Clinics, and Ambulatory Centers among others.
By Regions : Europe, North America, APAC and Rest of the World.

Global Yeast Infection Market - Regional analysis

The North America region accounts for the largest market share in the global yeast infection market followed by the Europe & Asia Pacific regions, respectively. The yeast infection market in North America is growing due to the significant contribution from the significantly increasing market for the U.S. due to the increasing number of patients suffering from immune diseases and presence of huge geriatric population.

Furthermore, the significant market share of the US market attributes to the growing prevalence of yeast infection coupled with the high expenditure on the health care. On the flip side, the regulatory changes in the US such as the implementation of the Affordable Care Act are expected to take a toll on the US yeast infection market.

On the other hand, the yeast infection market in Europe accounting for the world’s second-largest market is growing due to the higher per capita income and strong healthcare penetration in the region. Furthermore, factors such as the availability of advanced treatment facilities, skilled medical professionals, and government support for research & development drive the growth of the regional market in the large scale.

The Asia Pacific region is rapidly emerging as a lucrative market for the yeast infection. Countries such as China and India backed by the huge population and the low-cost medications and procedures available to treat the yeast infection foster the market growth in the region. Moreover, the rapidly growing healthcare sector coupled with the large unmet needs over the forecast period will provide impetus to the market growth.

Global Yeast Infection Market - Competitive Analysis

The global yeast infection market is a fragmented market with a large number of players. Increasing cases of drug resistance have opened doors for new drug development and opportunities for a new market leader. The increase of spurious and counterfeit medicines have reduced the total market revenues and at the same time displaced standard drugs off the market.

Key Players:

Some of the eminent leaders fostering the global yeast infection market include Synmedic Laboratories (India), Scynexis (US), Merck & Co., Inc. (US), Bayer AG (Germany), Astellas (Japan), Mentis Pharma Ltd. (India), Novartis AG (Switzerland), Abbott (US), Pfizer Inc. (US), ALLERGAN (Ireland), Sanofi (France), and AstraZeneca (UK).

Industry/Innovations/Related News:

October 05, 2018 – Researchers from the Technion-Israel Institute of Technology’s Faculty of Biotechnology and Food Engineering published in the journal Advanced Functional Materials the study of a Bacterial Gel they developed to fight yeast infections. They confirmed that they have successfully cured fungal infections in mice using a soil-dwelling bacterium.